Table of Contents

Clinical Studies

• You have access

  Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA

  JUHA ONATSU, MIKKO TAINA, PIRJO MUSTONEN, MARJA HEDMAN, ANTTI MUURONEN, OTSO ARPONEN, MIIKA KORHONEN, PEKKA JÄKÄLÄ, RITVA VANNINEN and KARI PULKKI

  In Vivo May 2017, 31 (3) 381-386;
• You have access

  Magnetic Resonance Imaging Assessment of Lipomatous Soft-tissue Tumors

  ALESSANDRO CORAN, PAOLO ORTOLAN, SHADY ATTAR, ENRICO ALBERIOLI, EGLE PERISSINOTTO, ANNA LISA TOSI, MARIA CRISTINA MONTESCO, CARLO RICCARDO ROSSI, SAVERIA TROPEA, MARCO RASTRELLI and ROBERTO STRAMARE

  In Vivo May 2017, 31 (3) 387-395;
• You have access

  Survival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre

  LINDA SKIBSTED KORNERUP, GITTE DAM and HENNING GRONBAEK

  In Vivo May 2017, 31 (3) 397-402;
• You have access

  Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Helicobacter pylori Infection in Gastric Cancer

  TAKASHI FUKUYAMA, NOBUE FUTAWATARI, YOSHINOBU ICHIKI, AKIKO SHIDA, TAIGA YAMAZAKI, YATSUSHI NISHI, HIROSHI NONOGUCHI, YOSHIHITO TAKAHASHI, HITOSHI YAMAZAKI and NORITADA KOBAYASHI

  In Vivo May 2017, 31 (3) 403-407;
• You have access

  Clinical Implication of the Width of Subserosal Invasion in T3N0 Gastric Cancer

  KENJI NAKAMURA, MIFUJI TOMIOKU, KAZUHITO NABESHIMA and EIJI NOMURA

  In Vivo May 2017, 31 (3) 409-413;
• You have access

  Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer

  PIETRO PEPE, DAVIDE D'URSO, ANTONIO GARUFI, GIANDOMENICO PRIOLO, MICHELE PENNISI, GIORGIO RUSSO, MARIA GABRIELLA SABINI, LUCIA MARIA VALASTRO, ANTONIO GALIA and FILIPPO FRAGGETTA

  In Vivo May 2017, 31 (3) 415-418;
• You have access

  Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases

  TOSHIAKI YOSHIMOTO, YUJI MORINE, SATORU IMURA, TETSUYA IKEMOTO, SYUICHI IWAHASHI, YU SAITO, SINICHIRO YAMADA, DAICHI ISHIKAWA, HIROKI TERAOKU, MASATO YOSHIKAWA, JUN HIGASHIJIMA, CHIE TAKASU and MITSUO SHIMADA

  In Vivo May 2017, 31 (3) 419-423;
• You have access

  Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment

  BALAZS NEMETH, ISTVAN KISS, TIMEA JENCSIK, IVAN PETER, ZITA KRESKA, TAMAS KOSZEGI, ATTILA MISETA, PETER KUSTAN, IMRE BONCZ, ANDREA LACZO and ZENO AJTAY

  In Vivo May 2017, 31 (3) 425-428;
• You have access

  Partial Cystectomy for Atypical Isolated Recurrence of Ovarian Adenocarcinoma – A Case Report and Literature Review

  NICOLAE BACALBASA and IRINA BALESCU

  In Vivo May 2017, 31 (3) 429-433;
• You have access

  A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder

  LISA MANIG, STEFAN JANSSEN, STEVEN E SCHILD and DIRK RADES

  In Vivo May 2017, 31 (3) 435-438;
• You have access

  Thrombotic Microangiopathy Following Chemotherapy with S-1 and Cisplatin in a Patient with Gastric Cancer: A Case Report

  JUN MUTO, HIROSHI KISHIMOTO, YASUO KAIZUKA, MITSURU KINJO, HIDEFUMI HIGASHI and FUMIAKI KISHIHARA

  In Vivo May 2017, 31 (3) 439-441;
• You have access

  IT-based Psychosocial Distress Screening in Patients with Sarcoma and Parental Caregivers via Disease-specific Online Social Media Communities

  FLORIAN POHLIG, ULRICH LENZE, HEINRICH M.L. MUHLHOFER, FLORIAN W. LENZE, JOHANNES SCHAUWECKER, CAROLIN KNEBEL, TANJA ZIMMERMANN and PETER HERSCHBACH

  In Vivo May 2017, 31 (3) 443-450;
• You have access

  Surgical Management of Non-small Cell Lung Cancer with Solitary Hematogenous Metastases

  GRIGORIOS KARAGKIOUZIS, ELEFTHERIOS SPARTALIS, DEMETRIOS MORIS, DEMETRIOS PATSOURAS, ATHANASIOS ATHANASIOU, IOANNIS KARATHANASIS, ALEXIOS VERVENIOTIS, FROSO KONSTANTINOU, ILIAS A. KOUERINIS, KONSTANTINOS POTARIS, DIMITRIOS DIMITROULIS and PERIKLIS TOMOS

  In Vivo May 2017, 31 (3) 451-454;
• You have access

  Definitive Intensity-modulated Radiation Therapy in Elderly Patients with Locally Advanced Oropharyngeal Cancer

  FRANCESCA DE FELICE, ALESSANDRO GALDIERI, GESSICA ABATE, NADIA BULZONETTI, DANIELA MUSIO and VINCENZO TOMBOLINI

  In Vivo May 2017, 31 (3) 455-459;
• You have access

  Testicular Dose During Prophylaxis of Heterotopic Ossification with Radiation Therapy

  WALEED F. MOURAD, JOHN K. MA, SATYASEELAN PACKIANATHAN, WEISI YAN, SHERIF G. SHAABAN, EDWARD M. MARCHAN, LAMIAA E. ABDALLAH, REI HE, PAUL N. MOBIT, CHUNLI (CLAUS) YANG and SRINIVASAN VIJAYAKUMAR

  In Vivo May 2017, 31 (3) 461-466;
• You have access

  Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders

  IVAN GENTILE, EMANUELA ZAPPULO, MARIA PIA RICCIO, SANDRO BINDA, LAURA BUBBA, LAURA PELLEGRINELLI, DOMENICO SCOGNAMIGLIO, FRANCESCA OPERTO, LUCIA MARGARI, GUGLIELMO BORGIA and CARMELA BRAVACCIO

  In Vivo May 2017, 31 (3) 467-473;
• You have access

  Rebiopsy of Histological Samples in Pretreated Non-small Cell Lung Cancer: Comparison Among Rebiopsy Procedures

  AKITO HATA, NOBUYUKI KATAKAMI, SHIGEKI NANJO, CHIYUKI OKUDA, REIKO KAJI and YUKIHIRO IMAI

  In Vivo May 2017, 31 (3) 475-479;
• You have access

  Ewing's Sarcoma Family Tumors in the Jaws: Case Report, Immunohistochemical Analysis and Literature Review

  ANA REGINA CASAROTO, MARCELO BONIFACIO DA SILVA SAMPIERI, CLEVERSON TEIXEIRA SOARES, PAULO SERGIO DA SILVA SANTOS, RENATO YASSUTAKA FARIA YAEDU, JOSÉ HUMBERTO DAMANTE and VANESSA SOARES LARA

  In Vivo May 2017, 31 (3) 481-491;
• You have access

  Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer

  JUNICHIRO WATANABE, YOSHINORI ITO, TOSHIAKI SAEKI, NORIKAZU MASUDA, TOSHIMI TAKANO, SHINTARO TAKAO, KAZUHIKO NAKAGAMI, KOICHIRO TSUGAWA, SHINTARO NAKAGAWA, KAZUMITSU KANATANI and TAKAHIRO NAKAYAMA

  In Vivo May 2017, 31 (3) 493-500;